DR. NASSER NASSERI-ASL MD NPI 1437119047

NPI Details

DR. Nasser Nasseri-asl, MD is a specialist in Catonsville, MD with 27 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Nasser Nasseri-asl, MD NPI is 1437119047. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

700 GEIPE RD STE 200
CATONSVILLE, MD
ZIP 21228-176
Phone: (410) 744-0661
Fax: (410) 744-8036

The NPI 1437119047 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Complete ultrasound scan of joint (HCPCS:76881)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Vitamin d-3 level (HCPCS:82306)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Rheumatoid factor level (HCPCS:86431)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Automated urinalysis test (HCPCS:81003)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Acute hepatitis panel (HCPCS:80074)
• Screening test for autoimmune disorder (HCPCS:86038)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Uric acid level, blood (HCPCS:84550)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
• Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Ultrasonic guidance for needle placement (HCPCS:76942)

The enumeration date for this NPI number is 3/27/2006 and was last updated on 1/31/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: